Archive | Uncategorized RSS feed for this section

iPSC Sub-study Complete

PPMI is a nimble study designed to allow for quick adaptation to emerging needs in the Parkinson’s disease (PD) research field.  In response to increased interest from researchers in well-characterized induced pluripotent stem cells (iPSCs) adult cells capable of giving rise to any human cell type, PPMI launched the Golub Capital iPSC Sub-Study in collaboration […]

Continue reading...

Update: PPMI iPSC Lines

Cell lines derived from PPMI participants, PBMCs become available on a rolling basis as they are reprogrammed; some lines are available now. For more information, please email resources@michaeljfox.org. Information about additional tools for PD research, including animal models, antibodies, and assays, can be found on the Michael J. Fox Foundation website.   The Parkinson’s Progression […]

Continue reading...

PPMI Q1 2016 Study Update call

On March 11, Dr. Mark Frasier, Senior Vice President at the Michael J. Fox Foundation, shared an update on the PPMI study. Dr. Frasier summarized some of the key accomplishments of PPMI to date.

Continue reading...

Dr. Omar El-Agnaf to use PPMI biospecimens for validation of cerebral spinal fluid ?-synuclein species as surrogate biomarkers for Parkinson?s disease

We are excited to announce another recent approval by our Biospecimen Review Committee. Dr. Omar El-Agnaf, Professor at Hamad Bin Khalifa University in Doha, Qatar, will be using PPMI biospecimens for a project entitled: Validation of CSF ?-synuclein species as surrogate biomarkers for Parkinson?s disease. Dr. El-Agnaf has recently reported higher levels of the oligomeric […]

Continue reading...

New Feature: PPMI Biospecimen Inventory

An inventory of available biospecimens in PPMI can now be accessed on www.ppmi-info.org. This regularly updated table reflects the number of samples that are currently available for analysis by visit and type of sample. This is a key tool for researchers looking to request specimens to be analyzed for biomarker verification studies. This inventory table now provides researchers with real-time numbers of specimens available before submitting a request.

Continue reading...